OrbiMed Israel GP Ltd.
- SEC CIK
- 0001569590
In the past year, 1 open-market purchase filing worth $5.00M and 1 sale filing worth $674.8K.
Current role at each company
- ACET Adicet Bio, Inc.10% Owneras of Apr 9, 2026
- HLSQ Tessera Defense & Homeland Security Inc.10% Owneras of May 20, 2024
- CMMB Chemomab Therapeutics Ltd.10% Owneras of Jan 5, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $5.00M
- 1 filing
- Sold
- $674.8K
- 1 filing
- Net
- +$4.33M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists OrbiMed Israel GP Ltd. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ACET Adicet Bio, Inc.
10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 (view filing)5:38 PM ET | Apr 7-8 | 2 days | OrbiMed Advisors LLC and 7 others10% Owner | SSale | −104.7K | $6.45 | −$674.8K | −100.0%0 after | 4 lots |
| Oct 10, 2025 (view filing)8:06 PM ET | Oct 8 | 2 days | OrbiMed Advisors LLC and 7 others10% Owner | PPurchase | +5.00M | $1.00 | +$5.00M | New position4.49M after | 2 lots |
| Jan 26, 2024 (view filing)7:14 PM ET | Jan 25 | 1 day | OrbiMed Advisors LLC and 7 othersDirector, 10% Owner | PPurchase | +3.13M | $2.40 | +$7.50M | New position1.26M after | 3 lotsDuplicate filing |
| Jun 29, 2023 (view filing)4:46 PM ET | Jun 27 | 2 days | OrbiMed Advisors LLC and 8 othersDirector, 10% Owner | PPurchase | +875.0K | $2.09 | +$1.83M | New position748.1K after | 4 lotsDuplicate filing |
HLSQ Tessera Defense & Homeland Security Inc.
10% Owner6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2024 (view filing)4:39 PM ET | May 15 | 5 daysLate | Gordon Carl L and 3 others10% Owner | SSale | −24.3K | $0.3812 | −$9.28K | −0.2%13.8M after | |
| Mar 19, 2024 (view filing)9:06 PM ET | Mar 15 | 4 days | Gordon Carl L and 3 others10% Owner | PPurchase | +6.49M | – | – | –2.16M after | Derivative2 lots |
| Mar 17, 2023 (view filing)4:29 PM ET | Feb 27 | 18 daysLate | Gordon Carl L and 3 others10% Owner | PPurchase | +348.0K | $0.245 | +$85.3K | +12.4%3.16M after | |
| Mar 17, 2023 (view filing)4:29 PM ET | Feb 27 | 18 daysLate | Gordon Carl L and 3 others10% Owner | PPurchase | +1.79M | – | – | –1.79M after | Derivative |
| Jul 30, 2021 (view filing)6:20 PM ET | Jul 28 | 2 days | OrbiMed Israel GP Ltd. and 1 other10% Owner | PPurchaseCommon Stock, $0.0001 par value | +500.0K | – | – | +21.6%2.81M after | |
| Jul 30, 2021 (view filing)6:20 PM ET | Jul 28 | 2 days | OrbiMed Israel GP Ltd. and 1 other10% Owner | PPurchase | +375.0K | – | – | –375.0K after | Derivative |
CMMB Chemomab Therapeutics Ltd.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 (view filing)4:49 PM ET | Jan 3 | 2 days | OrbiMed Israel GP Ltd. and 1 other10% Owner | SSaleAmerican Depository Shares | −336.9K | $3.58 | −$1.21M | −13.1%2.24M after | 2 lots |